CooperVision leader comments on products and acquisitions

Article

Jerry Warner, executive vice president Americas and global commercial functions at CooperVision, spoke in a one-on-one interview about the company’s recent product expansions and place in the market. The discussion took place at Vision Expo East 2021 in Orlando, Florida.

Product launch and expansion

The company plans a soft launch of My Day multifocal contact lens this summer. The lens will feature a new multifocal design, including a +3.00 D add. Warner says the lens is offering an 80% success rate with first fits and 90% with second fits.

“Technology in multifocals is one of the things that if it excited doctors, it excites patients,” says Warner. “This is an opportunity to reengage in the presbyopia segment. Many patients are passionate about staying in contact lenses.”

He confirms that the company will add a multifocal toric daily disposable lens to its portfolio. However, he did not offer a timeline for the launch.

“If any company is going to do it, we will,” he says. “I don’t doubt our know-how to be able to do it.”

The company recently expanded the range of lenses in the toric market:

• Range of Biofinity made-to-order torics

• Range of My Day toric, offering the largest range in the market, Warner says. “By early 2022, we will expand the range of My Day toric to that of Biofinity toric.”

Acquisitions

Warner says that acquiring companies and technology furthers CooperVision’s footprint in 2 areas, orthokeratology (ortho-k) and scleral lenses, which allows the company to grow in new directions.

This growth began with the initial acquisition of Paragon Vision Sciences in December 2017. Paragon received FDA approval for its Corneal Refractive Therapy contact lens system in 2002.

In April 2021, CooperVision acquired No7 Contact Lenses, joining recent acquisitions of GP Specialists, and Blanchard Contact Lenses.

In addition, the company partnered with Essilor to create a 50-50 joint venture in the acquisition of SightGlass. SightGlass develops spectacle lenses to reduce myopia progression in children.

Myopia management fits into CooperVision’s wheelhouse with its specialty lens division and launch of MiSight 1-day disposable contact lenses to reduce myopia progression.

“You have to think about spectacle lenses,” says Warner. “We wanted to [acquire SightGlass] with a partnership.”

He predicts that myopia management will broaden quickly due to new players and technology coming to market.

“If you can accelerate uptake, kids will benefit the most,” he says.

Recent Videos
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
ODs share what they learned at this year's Academy meeting and what they plan to take home to their practices.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."
Ahmad Fahmy at AAOpt on neurotrophic pain in OSD
Erin Tomiyama, OD, PhD, FAAO, discusses fitting lenses, young adults with binocular vision issues, and emerging presbyopia in patients.
Jamie Kuzniar, OD, FAAO, FSLS, overviews the basics on what to look out for complications-wise in corneal transplant patients that may require a referral.
Dr. Lisa Hornick goes over cosmetic habits and digital eye strain factors in OSD
© 2024 MJH Life Sciences

All rights reserved.